Citius Oncology, Inc.
CTORFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Citius Oncology, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Sep 30, 2025. The latest insider filing shown is dated Dec 22, 2025. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 264,733 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 36,840 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 45,746 | Not shown | SEC filing |
| Arkadios Wealth Advisors | 2026-03-31 | 11,666 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 1 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 47,454 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 3,835,160 | Not shown | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 186 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 10,125 | Not shown | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 9,188,855 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 42,900 | Not shown | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 107,424 | Not shown | SEC filing |
| IFP Advisors, Inc | 2025-12-31 | 87,424 | Not shown | SEC filing |
| OMERS ADMINISTRATION Corp | 2025-12-31 | 104,500 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2025-12-31 | 214 | Not shown | SEC filing |
| ROYAL BANK OF CANADA | 2025-12-31 | 23 | Not shown | SEC filing |
| VANGUARD GROUP INC | 2025-12-31 | 596,997 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-12-31 | 3 | Not shown | SEC filing |
| Arkadios Wealth Advisors | 2025-12-31 | 11,666 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2025-12-31 | 220,047 | Not shown | SEC filing |
- Each value is checked against Citius Oncology, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- IFP Advisors, Inc: 87,424 shares reported 2025-12-31; 107,424 shares reported 2026-03-31.
- STATE STREET CORP: 42,900 shares reported 2025-12-31; 42,900 shares reported 2026-03-31.
- ARMISTICE CAPITAL, LLC: 5,584,080 shares reported 2025-12-31; 9,188,855 shares reported 2026-03-31.
- OSAIC HOLDINGS, INC.: 11,425 shares reported 2025-12-31; 10,125 shares reported 2026-03-31.
- ROYAL BANK OF CANADA: 23 shares reported 2025-12-31; 186 shares reported 2026-03-31.
- BANK OF AMERICA CORP /DE/: 214 shares reported 2025-12-31; 3,835,160 shares reported 2026-03-31.
- BlackRock, Inc.: 22,344 shares reported 2025-12-31; 47,454 shares reported 2026-03-31.
- Arkadios Wealth Advisors: 11,666 shares reported 2025-12-31; 11,666 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 45,746 shares reported 2025-12-31; 45,746 shares reported 2026-03-31.
- UBS Group AG: 21,464 shares reported 2025-12-31; 36,840 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 220,047 shares reported 2025-12-31; 264,733 shares reported 2026-03-31.
- IFP Advisors, Inc: 33,215 shares reported 2025-09-30; 87,424 shares reported 2025-12-31.
Showing the 12 most recent filer reports.
9 filers have only one report here.
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-09-19 (amended) | Holuka Eugene Myron · Director | Common Stock | A — Grant, award, or other acquisition | +300,000 | SEC filing |
| 2025-09-19 (amended) | Czuczman Myron · Chief Medical Officer | Common Stock | A — Grant, award, or other acquisition | +825,000 | SEC filing |
| 2025-09-19 (amended) | Mayersohn Joel David · Director | Common Stock | A — Grant, award, or other acquisition | +300,000 | SEC filing |
| 2025-09-19 | HOLUBIAK MYRON Z · Secretary | Common Stock | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2025-09-19 (amended) | Mazur Leonard L · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +1,700,000 | SEC filing |
| 2025-09-19 (amended) | MCGRATH DENNIS M · Director | Common Stock | A — Grant, award, or other acquisition | +300,000 | SEC filing |
| 2025-09-19 (amended) | Dutia Suren G · Director | Common Stock | A — Grant, award, or other acquisition | +300,000 | SEC filing |
| 2025-09-19 (amended) | Webb Carol · Director | Common Stock | A — Grant, award, or other acquisition | +300,000 | SEC filing |
Showing 8 of 10 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-07-28 | Mayersohn Joel David · Director | Common Stock | J — Other acquisition or disposition | +21,228 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.